# Oligo-metastases NPC Patients Received Radiation for Primary Tumors and Treatments for Metastatic Lesions

> **NCT03129412** · PHASE2 · UNKNOWN · sponsor: **Zhejiang Cancer Hospital** · enrollment: 64 (estimated)

## Conditions studied

- Nasopharyngeal Cancer
- Neoplasm Metastasis

## Interventions

- **RADIATION:** radical radiotherapy

## Key facts

- **NCT ID:** NCT03129412
- **Lead sponsor:** Zhejiang Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-04-14
- **Primary completion:** 2023-04-23
- **Final completion:** 2025-04-23
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2020-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03129412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03129412, "Oligo-metastases NPC Patients Received Radiation for Primary Tumors and Treatments for Metastatic Lesions". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03129412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*